REG - Haleon PLC - Results of Haleon 2025 Annual General Meeting

HALEONAnnouncement

28/05/2025 18:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250528:nRSb4935Ka&default-theme=true

RNS Number : 4935K  Haleon PLC  28 May 2025

 

 

Haleon plc: Results of Haleon 2025 Annual General Meeting

 

28 May 2025: Haleon plc (the "Company" or "Haleon) (LSE/NYSE: HLN) announces
that the following resolutions were decided by poll vote at the Company's 2025
Annual General Meeting ("AGM") which was held today.

 

Resolutions 19, 20, 21 and 22 were passed as special resolutions; all other
resolutions were passed as ordinary resolutions. Full text of the resolutions
is contained in the Company's Notice of AGM, which is available at
www.haleon.com (http://www.haleon.com) .

 

Haleon plc - Poll Results

 

 Resolution                                                                             Votes for      For (% of shares voted)  Votes against  Against (% of shares voted)  Total votes cast (excluding withheld)  % of issued share capital voted(1)  Votes withheld(2)
 1       To receive the Annual Report & Accounts                                        7,517,144,325  99.99                    842,368        0.01                         7,517,986,693                          83.48                               65,369,244
 2       To approve the Directors' Remuneration Report                                  7,428,243,215  98.73                    95,579,831     1.27                         7,523,823,046                          83.54                               59,533,076
 3       To declare a final dividend                                                    7,524,186,981  99.99                    923,515        0.01                         7,525,110,496                          83.56                               58,245,442
 4       To re-elect Sir Dave Lewis                                                     7,498,843,821  99.66                    25,860,104     0.34                         7,524,703,925                          83.55                               58,652,013
 5       To re-elect Brian McNamara                                                     7,522,242,013  99.97                    2,587,699      0.03                         7,524,829,712                          83.55                               58,526,226
 6       To elect Dawn Allen                                                            7,483,140,783  99.45                    41,558,848     0.55                         7,524,699,631                          83.55                               58,654,043
 7       To re-elect Manvinder Singh (Vindi) Banga                                      7,519,740,136  99.94                    4,786,625      0.06                         7,524,526,761                          83.55                               58,829,175
 8       To elect Nancy Avila                                                           7,516,944,426  99.90                    7,674,923      0.10                         7,524,619,349                          83.55                               58,736,587
 9       To re-elect Marie-Anne Aymerich                                                7,516,731,352  99.91                    6,797,652      0.09                         7,523,529,004                          83.54                               59,826,931
 10      To elect Bláthnaid Bergin                                                      7,520,233,253  99.94                    4,257,800      0.06                         7,524,491,053                          83.55                               58,864,884
 11      To re-elect Tracy Clarke                                                       7,500,339,471  99.68                    24,261,558     0.32                         7,524,601,029                          83.55                               58,754,908
 12      To re-elect Dame Vivienne Cox                                                  7,509,748,919  99.80                    14,871,809     0.20                         7,524,620,728                          83.55                               58,731,806
 13      To re-elect Asmita Dubey                                                       7,510,543,577  99.81                    14,014,288     0.19                         7,524,557,865                          83.55                               58,798,072
 14      To elect Alan Stewart                                                          7,522,008,446  99.97                    2,330,160      0.03                         7,524,338,606                          83.55                               59,005,235
 15      To re-appoint KPMG as auditor of the Company                                   7,521,601,516  99.95                    3,522,152      0.05                         7,525,123,668                          83.56                               58,232,270
 16      To authorise the Audit & Risk Committee to set the auditor's remuneration      7,522,283,299  99.97                    2,583,886      0.03                         7,524,867,185                          83.55                               58,488,752
 17      To authorise the Company to make political donations                           7,440,921,749  98.88                    84,625,992     1.12                         7,525,547,741                          83.56                               57,811,937
 18      To authorise the Directors to allot ordinary shares                            7,187,533,051  95.52                    336,762,607    4.48                         7,524,295,658                          83.55                               59,060,278
 19      General authority to disapply pre-emption rights                               7,213,281,442  95.88                    309,833,429    4.12                         7,523,114,871                          83.53                               60,241,065
 20      Additional authority to disapply pre-emption rights                            7,039,904,846  93.58                    483,263,460    6.42                         7,523,168,306                          83.53                               60,187,475
 21      To authorise a 14-day notice period for general meetings                       6,957,683,132  92.46                    566,988,704    7.54                         7,524,671,836                          83.55                               58,684,099
 22      To authorise the Company to purchase its own shares                            7,516,118,031  99.92                    5,793,689      0.08                         7,521,911,720                          83.52                               61,444,405

 

(1) For the purposes of section 341 of the Companies Act 2006, as at 6:30pm
(BST) on Friday 23 May 2025, Haleon's issued share capital was 9,010,139,389
ordinary shares of £0.01 each, 4,080,205 of which were held as treasury
shares. Therefore, the total voting rights in the Company were 9,006,059,184.

(2) A "Vote withheld" is not a vote in law and is not counted in the
calculation of the votes "For" or "Against" a resolution.

 

As required by the UK Listing Rule 6.4.2R of the Financial Conduct Authority
("FCA"), copies of resolutions passed by the Company other than resolutions
concerning ordinary business have been submitted to the FCA via the National
Storage Mechanism and will shortly be available to the public for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans six major categories - Oral Health, Vitamins, Minerals and Supplements
(VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin
Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on
trusted science, innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGQVLFLEELEBBZ